» Articles » PMID: 37337552

Lung Ultrasound Score Severity Cut-off Points in COVID-19 Pneumonia. A Systematic Review and Validating Cohort

Abstract

Objectives: Our purpose was to establish different cut-off points based on the lung ultrasound score (LUS) to classify COVID-19 pneumonia severity.

Methods: Initially, we conducted a systematic review among previously proposed LUS cut-off points. Then, these results were validated by a single-centre prospective cohort study of adult patients with confirmed SARS-CoV-2 infection. Studied variables were poor outcome (ventilation support, intensive care unit admission or 28-days mortality) and 28-days mortality.

Results: From 510 articles, 11 articles were included. Among the cut-off points proposed in the articles included, only the LUS > 15 cut-off point could be validated for its original endpoint, demonstrating also the strongest relation with poor outcome (odds ratio [OR] = 3.636, confidence interval [CI] 1.411-9.374). Regarding our cohort, 127 patients were admitted. In these patients, LUS was statistically associated with poor outcome (OR = 1.303, CI 1.137-1.493), and with 28-days mortality (OR = 1.024, CI 1.006-1.042). LUS > 15 showed the best diagnostic performance when choosing a single cut-off point in our cohort (area under the curve 0.650). LUS ≤ 7 showed high sensitivity to rule out poor outcome (0.89, CI 0.695-0.955), while LUS > 20 revealed high specificity to predict poor outcome (0.86, CI 0.776-0.917).

Conclusions: LUS is a good predictor of poor outcome and 28-days mortality in COVID-19. LUS ≤ 7 cut-off point is associated with mild pneumonia, LUS 8-20 with moderate pneumonia and ≥20 with severe pneumonia. If a single cut-off point were used, LUS > 15 would be the point which better discriminates mild from severe disease.

References
1.
Boero E, Rovida S, Schreiber A, Berchialla P, Charrier L, Cravino M . The COVID-19 Worsening Score (COWS)-a predictive bedside tool for critical illness. Echocardiography. 2021; 38(2):207-216. PMC: 8013873. DOI: 10.1111/echo.14962. View

2.
Ji L, Cao C, Gao Y, Zhang W, Xie Y, Duan Y . Prognostic value of bedside lung ultrasound score in patients with COVID-19. Crit Care. 2020; 24(1):700. PMC: 7754180. DOI: 10.1186/s13054-020-03416-1. View

3.
Smith M, Hayward S, Innes S, Miller A . Point-of-care lung ultrasound in patients with COVID-19 - a narrative review. Anaesthesia. 2020; 75(8):1096-1104. PMC: 7262296. DOI: 10.1111/anae.15082. View

4.
Collins G, Reitsma J, Altman D, Moons K . Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD Statement. Br J Surg. 2015; 102(3):148-58. DOI: 10.1002/bjs.9736. View

5.
Song G, Qiao W, Wang X, Yu X . Association of Lung Ultrasound Score with Mortality and Severity of COVID-19: A Meta-Analysis and Trial Sequential Analysis. Int J Infect Dis. 2021; 108:603-609. PMC: 8266421. DOI: 10.1016/j.ijid.2021.06.026. View